what's trending

5 most popular innovation stories in Houston this week

From innovators to know to grant funding for a new health tech company, here are this week's trending stories. Photo by Shobeir Ansari/Getty Images

Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, grant funding for a new health tech company, a new Houston HQ for an international company, and more.

3 Houston innovators to know this week

This week's roundup of Houston innovators includes Bill Voss of Everest, Day Edwards of ChurchSpace, and Tim Neal of GoExpedi. Photos courtesy

In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from e-commerce to the '"AirBNB for churches" — recently making headlines in Houston innovation. Click here to continue reading.

Houston entrepreneur on how he cooked up a new career

How Tasos Katsaounis took his pandemic hobby and let it rise into a booming Houston business. Image via breadmanco.com

Four years ago, while looking to escape the daily rigors of his corporate work stress, Houstonian Tasos Katsaounis began to bake bread between Zoom calls.

And while for many during the pandemic it became somewhat of a cliché to bake sourdough at home, Katsaounis was getting a head start on developing the ingredients for Bread Man Baking Co. – a Houston-based artisan bread business that can now be tasted in restaurants all throughout the city.

“You know, there’s just something about the idea of growing something from nothing,” Katsaounis, CEO and founder of the company, tells InnovationMap. “I really feel like for the first time in my 26 years of working professionally, that I'm doing what I'm supposed to be doing and I'm super passionate about what I do every day.” Click here to continue reading.

London-based data management tech firm announces new Houston HQ, CEO

Philip Dutton is the new Houston-based CEO of Solidatus, a London-founded data management startup. Photo via LinkedIn

As part of a company reorganization, data management startup Solidatus has established Houston as its North American headquarters and has named co-founder Philip Dutton as its Houston-based CEO.

Founded in London in 2017, Solidatus initially focused on supplying data management software to businesses in Europe, the Middle East, and Africa, but has since extended its reach to North America. Overall, Solidatus employs more than 110 people. It plans to triple its U.S. headcount over the next year.

“Solidatus serves visionary organizations that desire streamlined access and clarity of their data to build smarter and more profitable businesses. That’s everyone from Fortune 500 companies that have an unmanageably complex data landscape to startups and scale-ups that want to optimize their data practices from the get-go. There is no greater concentration of these organizations than in the U.S.,” Dutton, who had been the co-CEO, says in a news release. Click here to continue reading.

University of Houston: What a drop in NSF proposals means for the country's rate of innovation

If there are fewer grant proposals, does that mean innovation has slowed? UH gets to the bottom of the question. Graphic byMiguel Tovar/University of Houston

A 17 percent drop in proposals over the past decade to the National Science Foundation may be a mixed blessing.

A consistently rising budget – and this is in billions of dollars – is the preferred method of keeping the number of funded proposals ever higher. But a dip in the number of proposals submitted in the first place can have a similar effect of increasing the number of funded proposals, since the pool of submissions is much smaller.

In an article for Science Magazine, author Jeffrey Mervis poses the question: Has there been a decline in grant-worthy ideas? In NSF’s biology sector, Mervis notes that “demand has tumbled by 50 percent over the decade and the chances of winning a grant have doubled, from 18 percent in 2011 to 36 percent in 2020.” NSF’s leadership suggests two possible reasons for this phenomenon. Click here to continue reading.

Houston lung cancer diagnostics startup launches, snags $3M grant

Prana Thoracic Inc., a medical device company developing a tool for early interception of lung cancer, announced a $3 million grant from CPRIT. Photo via Getty Images

An oncology device company has secured a grant from the Cancer Prevention and Research Institute of Texas, the startup announced this week.

Houston-based Prana Thoracic Inc., a medical device company developing a tool for early interception of lung cancer, announced that Nucore Medical Inc., its wholly owned subsidiary, has been awarded a $3 million grant from CPRIT. The funding will support first-in-human studies and commercialization of Prana Thoracic’s technology.

“We’re excited to be recognized by CPRIT and believe this award speaks to the potential of Prana Thoracic’s surgical oncology devices,” says Joanna Nathan, CEO and founder of Prana Thoracic, in a news release. "This funding will accelerate our technology to the bedside, enabling us to provide Texans and patients all over the world with a definitive diagnosis of their pulmonary nodules earlier in their patient journey." Click here to continue reading,

Trending News

Building Houston

 
 

Houston-based Melax Tech has developed multiple Natural language processing tools that are used by more than 650 health care and life science organizations. Photo via MelaxTech.com

Melax Tech Partners, a leader in natural language technology processing, announced a new partnership with the University of California at Irvine that will help researchers derive insights from the UCI Health Data Science Platform’s electronic health records system and improve patient care.

Melax will implement its signature text annotation tool LANN to pull information from clinical notes, and its CLAMP product to develop natural language processing customizations through the use of AI, according to a statement from the company.

“There has been a strong desire among UCI researchers to have the capability to analyze free-text clinical narrative data using cutting-edge NLP technologies," Kai Zheng, chief research information officer at UCI Health Affairs, says in a statement. "We are delighted to have this opportunity to work with Melax Tech to deploy their AI-driven annotation and analytics tools to help our researchers advance their research agenda by leveraging the vast amount of free-text data that our health system has accumulated in the past two decades.”

Natural language processing, or NLP, allows organizations and healthcare groups to sift through and analyze massive amounts of data at a rapid rate through the use of machine learning and AI. Houston-based Melax Tech, founded in 2017, has developed multiple NLP tools that are used by more than 650 health care and life science organizations, according to its website.

In addition to the recent partnership with UC Irvine, Melax has also recently partnered with Vanderbilt University Medical Center and the University of Western Pennsylvania on similar clinical projects.

Melax has also used its platforms to pull vital information from datasets relating to COVID-19, in both medical and social settings.

In March 2022, it was awarded a Phase 1 NIH Award, valued at $300,000, to develop informatics tools based on COVID-19 datasets with the San Diego Supercomputer Center at UC San Diego. The tool aims to help researchers better understand vast amounts of virus-related data and connect findings with other similar results.

In August, Melax also received another $300,000 grant from the National Institute of Allergy and Infectious Diseases to develop NLP-based algorithms that will "model, extract and synthesize vaccine misinformation from multiple popular social media sources," according to a statement. Melax will also develop a visualization that presents its findings on the misinformation into a compressible format.

"This is a very real topic affecting culture at present," Andre Pontin, CEO at Melax Tech, says in a statement. "And shows that we as a collective business and group of experts continue to be on the cutting-edge of science in the NLP and AI domain."

Trending News